Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations

European Journal of Clinical Investigation

Volumn 29, Issue 2, 1999, Pages 116-128

  Gudnason, V ^c   Kakko, S ^d   Nicaud, V ^a   Savolainen, M J ^d   Kesaniemi Y A ^d   Tahvanainen, E ^b   Humphries, S ^d  

^a INSERM   (France)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d National Public Health Institute ^*

Author keywords

Cholesteryl ester transfer protein; Coronary artery disease risk; Genetic polymorphisms; High density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; EUROPE; EXON; FAMILY HISTORY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; INTRON; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROGENY; VARIANCE;

EID: 0033065475     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00412.x     Document Type: Article

References (63)

1. 1 Pattnaik NM, Montes A, Hughes LB, Zilversmit DB. Cholesteryl ester exchange protein in human plasma isolation and characterization. Biochim Biophys Acta 1978; 530: 428-38.
2. 2 Chajek T, Fielding CJ. Isolation and characterization of a human serum cholesteryl ester transfer protein. Proc Natl Acad Sci USA 1978; 75: 3445-9.
3. 3 Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984; 4: 49-58.
4. 4 Hesler CB, Swenson TL, Tall AR. Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem 1987; 262: 2275-82.
5. 5 Morton RE, Zilversmit DB. Inter-relationship of lipids transferred by the lipid-transfer protein isolated from human lipoprotein-deficient plasma. J Biol Chem 1983; 258: 11751-7.
6. 6 Marcel YL, Vezina C, Teng B, Sniderman A. Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor. Atherosclerosis 1980; 35: 127-33.
7. 7 Dullaart RP, Groener JE, Erkelens DW. Effect of the composition of very low and low density lipoproteins on the rate of cholesterylester transfer from high density lipoproteins in man, studied in vitro. Eur J Clin Invest 1987; 17: 241-8.
8. 8 Guerin M, Dolphin PJ, Chapman MJ. Preferential cholesteryl ester acceptors among the LDL subspecies of subjects with familial hypercholesterolemia. Arterioscler Thromb 1994; 14: 679-85.
9. 9 Nikkila E. Studies on the lipid-protein relationships in normal and pathologic sera and the effect of heparin on serum lipoproteins. Scand J Clin Lab Invest 1953; 5: 1-101.
10. 10 Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1975; 1: 16-9.
11. 11 Gordon TW, Castelli P, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-14.
12. 12 Tollefson JH, Ravnik S, Albers JJ. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J Lipid Res 1988; 29: 1593-602.
13. 13 Freeman DJ, Packard CJ, Shepherd J, Gaffney D. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci Colch 1990; 79: 575-81.
14. 14 Hannuksela ML, Liinamaa MJ, Kesaniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994; 110: 35-44.
15. 15 Savolainen MJ, Hannuksela M, Seppanen S, Kervinen K, Kesaniemi YA. Increased high-density lipoprotein cholesterol concentration in alcoholics is related to low cholesteryl ester transfer protein activity. Eur J Clin Invest 1990; 20: 593-9.
16. 16 Kuivenhoven JA, de Knijff P, Boer JM, et al. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol 1997; 17: 560-8.
17. 17 Tato F, Vega GL, Tall AR, Grundy SM. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 112-20.
18. 18 Foger B, Ritsch A, Doblinger A, Wessels H, Patsch JR. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. Arterioscler Thromb Vasc Biol 1996; 16: 1430-6.
19. 19 Zhao SP, Smelt AH, Van den Maagdenberg AM, et al. Plasma lipoprotein profiles of normocholesterolemic and hypercholesterolemic homozygotes for apolipoprotein E2 (Arg158→Cys) compared. Clin Chem 1994; 40: 1559-66.
20. 20 Kahri J, Syvanne M, Taskinen MR. Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease. Metabolism 1994; 43: 1498-502.
21. 21 Hayek T, Masucci Magoulas L, Jiang X, et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995; 96: 2071-4.
22. 22 Marotti KR, Castle CK, Boyle TP, Lin AH, Murray RW, Melchior GW. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein. Nature 1993; 364: 73-5.
23. 23 Zhong S, Sharp DS, Grove JS, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917-23.
24. 24 Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-71.
25. 25 Agellon LB, Quinet EM, Gillette TG, Drayna DT, Brown ML, Tall AR. Organization of the human cholesteryl ester transfer protein genes. Biochemistry 1990; 29: 1372-6.
26. 26 Drayna D, Jarnagin AS, McLean J, et al. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 1987; 327: 632-4.
27. 27 Drayna D, Lawn R. Multiple RFLPs at the human cholesteryl ester transfer protein (CETP) locus. Nucleic Acids Res 1987; 15: 4698.
28. 28 Inazu A, Brown ML, Hesler CB, et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med 1990; 323: 1234-8.
29. 29 Kondo I, Berg K, Drayna D, Lawn RDNA. polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989; 35: 49-56.
30. 30 Mendis S, Shepherd J, Packard CJ, Gaffney D. Genetic variation in the cholesteryl ester transfer protein and apolipoprotein A-I genes and its relation to coronary heart disease in a Sri Lankan population. Atherosclerosis 1990; 83: 21-7.
31. 31 Freeman DJ, Griffin BA, Holmes AP, et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb 1994; 14: 336-44.
32. 32 Funke H, Wiebusch H, Fuer L, Muntoni S, Schulte H, Assman G. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol (Abstract). Circulation 1994; 90: (pt 2): I; 241.
33. 33 Gudnason V, Thormar K, Humphries SE. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and non-smoking healthy men, and the effect on plasma HDL cholesterol and apoAI concentration. Clin Genet 1997; 51: 15-21.
34. 34 The European Atherosclerosis Research Study (EARS.): design and objectives. Int J Epidemiol 1994; 23: 465-71.
35. 35 Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737-44.
36. 36 Groener JE, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986; 32: 283-6.
37. 37 Miller SA, Dykes DD, Polesky HFA. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
38. 38 Bolla MK, Haddad L, Humphries SE, Winder AF, Day IN. High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin Chem 1995; 41: 1599-604.
39. 39 Day IN, Humphries SE. Electrophoresis for genotypes: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem 1994; 222: 389-95.
40. 40 Tiret L, Amouyel P, Rakotovao R, Cambien F, Ducimetiere P. Testing for association between disease and linked marker loci: a log-linear-model analysis. Am J Hum Genet 1991; 48: 926-34.
41. 41 Thompson EA, Deeb S, Walker D, Motulsky AG. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 1988; 42: 113-24.
42. 42 MacLean CJ, Morton NE. Estimation of myriad haplotype frequencies. Genet Epidemiol 1985; 2: 263-72.
43. 43 Henderson A. Coronary heart disease: overview. Lancet 1996; 348 (Suppl. 1): S1-4.
44. 44 Ritsch A, Auer B, Foger B, Schwarz S, Patsch JR. Polyclonal antibody-based immunoradiometric assay for quantification of cholesteryl ester transfer protein. J Lipid Res 1993; 34: 673-9.
45. 45 McPherson R, Mann CJ, Tall AR, et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relationship to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991; 11: 797-804.
46. 46 Quinet EM, Agellon LB, Kroon PA, et al. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest 1990; 85: 357-63.
47. 47 Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. J Clin Invest 1991; 87: 1559-66.
48. 48 Martin LJ, Connelly PW, Nancoo D, et al. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res 1993; 34: 437-46.
49. 49 Jiang XC, Moulin P, Quinet E, et al. Mammalian adipose tissue and muscle are major source of lipid transfer protein. J Biol Chem 1991; 266: 4631-9.
50. 50 Masucci Magoulas L, Plump A, Jiang XC, Walsh A, Breslow JL, Tall AR. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. J Clin Invest 1996; 97: 154-61.
51. 51 Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-94.
52. 52 Arai T, Yamashita S, Hirano K, et al. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 1994; 14: 1129-36.
53. 53 Radeau T, Lau P, Robb M, McDonnell M, Ailhaud G, McPherson R. Cholesteryl ester transfer protein (CETP) mRNA abundance in human adipose tissue: relationship to cell size and membrane cholesterol content. J Lipid Res 1995; 36: 2552-61.
54. 54 Freeman DJ, Griffin BA, Murrey E, et al. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993; 23: 630-40.
55. 55 Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994; 14: 1581-5.
56. 56 Tato F, Vega GL, Grundy SM. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vasc Biol 1997; 17: 56-63.
57. 57 Yamashita S, Hui DY, Wetterau JR, et al. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism 1991; 40: 756-63.
58. 58 Groener JEM, Van Rozen AJ, Erkelens DW. Cholesteryl ester transfer activity: localization and role in distribution of cholesteryl ester among lipoproteins in man. Atherosclerosis 1994; 50: 261-71.
59. 59 Nakanishi T, Tahara D, Akazawa S, Miyake S, Nagataki S. Plasma lipid transfer activities in hyper-high-density lipoprotein cholesterolemic and healthy control subjects. Metabolism 1990; 39: 225-30.
60. 60 Ritsch A, Drexel H, Amann FW, Pfeifhoefer C, Patsch JR. Deficiency of cholesteryl ester transfer protein. Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma. Arterioscler Thromb Vasc Biol 1997; 17: 3433-41.
61. 61 Karpe F, Bard JM, Steiner G, et al. HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. Arterioscler Thromb 1993; 13: 11-22.
62. 62 Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM Jr. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 1983; 80: 1449-53.
63. 63 Patsch JR, Prasad S, Gotto AM Jr, Patsch W. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of post-prandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-7.